Practice-Changing Education

Print

Past participants of this course consistently report that this program has inspired and improved their clinical practice and outcomes. Here are a few comments from attendees of the last offering of Thrombosis and Thromboembolism:
 

“After taking this course, I have increased and enhanced the organization, quality and scope of our anticoagulation clinic, of which I am the medical director.”
 

“I now have improved confidence in ordering tests and rx'ing NOACs, and improved understanding of the role of inflammation in thrombosis.”
 

“This course has led to better evaluation of who needs and who does not need thrombophilia lab testing, and a better understanding of and management of VTE in AFib patients.”
 

“All topics were relevant and presented with a clinically oriented view that made it very informative and practical.”
 

“As a primary care internist, a course such as this provides essential updates to take home.”
 

“I am a surgeon. I now have a better understanding of patients at risks for VTE and therapeutic modalities.”
 

“I have changed my reliance on results of coronary calcium scores, as well as my management of VTE in some low CHADS score patients.”
 

“My practice has updated its approach to PE risk evaluation and testing, and treatment of prevention of stroke in AF.”
 

“The convincing presentation of data on the efficacy and safety of NOACs, and how best to use in different patient populations, was pivotal— as well as information on the role of inflammation, evidence for and pending studies of the role of inflammation, and targeted therapies to assess if modifiable.”
 

“I have modified the treatment of hyperlipidemia, implemented the Reynolds Criteria and new lipid-lowering recommendations; also, with PE, I have advised our ER to risk stratify patients with Wells Criteria and D-dimer to decrease use of CTA.”  
 

“Some of the practice changes inspired by this course: I now definitely use more NOACs (data is dramatic); consider referring patients for catheter thrombolysis for PE; have updated my methodology for statin prescriptions.”
 

“I attend HMS CME courses on a regular basis. this is at the top in terms of presentations, faculty enthusiasm and applicability to office practice. Thanks!”
 

“I have addressed other physicians about overuse of thrombotic risk testing, and the use of evidence-based cost-effective assessment of PE.”
 

“Taking this course has assisted me in my administrative decision-making about hospital vs. non-hospital stays for anticoagulation.”
 

“I have updated my current coagulation policies and procedures.”
 

“All topics were extremely clinically relevant, speakers were exceptional, and it was an honor being able to listen to Dr. Braunwald.”
 

I am making better use of risk stratifying (European model) for PE treatment, using NOACs in a broader range of patients, and as a preferred treatment in AFib and PE.”
 

“Practice changes arising from taking this course are too numerous to list.”
 

“The speakers were dynamic and the material was comprehensive, current and packed solid. It was an excellent course!”
 

“I have updated my protocols for PE/DVT.”
 

“I had never heard of NETs before the course. I was impressed with the presentations on the evolving concepts in atherothrombosis and the biology of LDL.”
 

 “I am more comfortable prescribing NOACs in geriatrics; I follow evidence-based guidelines for diagnosing/ treating DVT/PE as well as using NOACs for treatment; I discuss anticoagulation options, including NOACs, with patients, and share this information with my colleagues.”
 

“I am teaching the resident staff regarding pathophysiology of thrombosis and anti-thrombotic therapy I gleaned at this course—statins, role of DAPTs, NOACs, etc.”
 

“This was an exceptionally well-run course with superb faculty—a very dynamic learning situation. I found the faculty back-and-forth highly stimulating.”
 

“The presence of the speakers during others’ talks and the long question periods were great!”
 

“This entire course is always exceptional.”